Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Conjunctivitis Market Research Report 2025

Global Conjunctivitis Market Research Report 2025

Industry: Pharma & Healthcare

Published Date: 2025-01-16

Pages: 82 Pages

Report ld: 3471525

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Conjunctivitis Market Size(US$)

CAGR 2025-2031

1.6%

Market Size,2031

USD 4,099

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 3,727 million

Market Forecast in 2031(Value)

US$ 4,099 million

CAGR

1.6%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Conjunctivitis was valued at US$ 3674 million in the year 2024 and is projected to reach a revised size of US$ 4099 million by 2031, growing at a CAGR of 1.6% during the forecast period.

Conjunctivitis, or inflammation of the conjunctiva, is a general term that refers to a diverse group of diseases/disorders that affect the conjunctiva primarily. Most varieties of conjunctivitis are self-limited, but some progress and may cause serious ocular and extraocular complications.

Conjunctivitis is more commonly referred to as pink eye. The whites of the eyes appear pink or red when the conjunctiva (the transparent membrane which lines part of the eyeball) becomes inflamed or infected.

The technical barriers of conjunctivitis industry are existed apparently. The key technology and higher level products are in the hand of the global leading enterprise like Novartis, Santen Pharmaceutical, Bausch + Lomb, Allergan, Sun Pharmaceutical, Akorn and Sinqi, etc.

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Conjunctivitis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Conjunctivitis.

The Conjunctivitis market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Conjunctivitis market comprehensively. Regional market sizes, concerning products by Type, by End User, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Conjunctivitis manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by End User, and by regions.

By Company

Novartis (CH)

Santen Pharmaceutical (JP)

Bausch & Lomb (US)

Allergan (US)

Sun Pharmaceutical (ID)

Akorn (US)

Freda (CN)

Sinqi (CN)

Univision (CN)

Segment by Type

Antibiotic

Pills

Ointment

Segment by End User

Newborns

Children

Adults

Consumption by Region

North America

U.S.

Canada

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Europe

Germany

France

U.K.

Italy

Russia

Latin America

Mexico

Brazil

Argentina

Middle East and Africa

Turkey

Saudi Arabia

U.A.E

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Conjunctivitis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Conjunctivitis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by End User, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Conjunctivitis Market Overview

1.1 Product Definition

1.2 Conjunctivitis by Type

1.2.1 Global Conjunctivitis Market Value Comparison by Type (2024 VS 2031)

1.2.2 Antibiotic

1.2.3 Pills

1.2.4 Ointment

1.3 Conjunctivitis by End User

1.3.1 Global Conjunctivitis Market Value by End User (2024 VS 2031)

1.3.2 Newborns

1.3.3 Children

1.3.4 Adults

1.4 Global Conjunctivitis Market Size Estimates and Forecasts

1.4.1 Global Conjunctivitis Revenue 2020-2031

1.4.2 Global Conjunctivitis Sales 2020-2031

1.4.3 Global Conjunctivitis Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Conjunctivitis Market Competition by Manufacturers

2.1 Global Conjunctivitis Sales Market Share by Manufacturers (2020-2025)

2.2 Global Conjunctivitis Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Conjunctivitis Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Conjunctivitis, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Conjunctivitis, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Conjunctivitis, Product Type & Application

2.7 Global Key Manufacturers of Conjunctivitis, Date of Enter into This Industry

2.8 Global Conjunctivitis Market Competitive Situation and Trends

2.8.1 Global Conjunctivitis Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Conjunctivitis Players Market Share by Revenue

2.8.3 Global Conjunctivitis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Conjunctivitis Market Scenario by Region

3.1 Global Conjunctivitis Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Conjunctivitis Sales by Region: 2020-2031

3.2.1 Global Conjunctivitis Sales by Region: 2020-2025

3.2.2 Global Conjunctivitis Sales by Region: 2026-2031

3.3 Global Conjunctivitis Revenue by Region: 2020-2031

3.3.1 Global Conjunctivitis Revenue by Region: 2020-2025

3.3.2 Global Conjunctivitis Revenue by Region: 2026-2031

3.4 North America Conjunctivitis Market Facts & Figures by Country

3.4.1 North America Conjunctivitis Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Conjunctivitis Sales by Country (2020-2031)

3.4.3 North America Conjunctivitis Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Conjunctivitis Market Facts & Figures by Country

3.5.1 Europe Conjunctivitis Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Conjunctivitis Sales by Country (2020-2031)

3.5.3 Europe Conjunctivitis Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Conjunctivitis Market Facts & Figures by Region

3.6.1 Asia Pacific Conjunctivitis Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Conjunctivitis Sales by Region (2020-2031)

3.6.3 Asia Pacific Conjunctivitis Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Conjunctivitis Market Facts & Figures by Country

3.7.1 Latin America Conjunctivitis Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Conjunctivitis Sales by Country (2020-2031)

3.7.3 Latin America Conjunctivitis Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Conjunctivitis Market Facts & Figures by Country

3.8.1 Middle East and Africa Conjunctivitis Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Conjunctivitis Sales by Country (2020-2031)

3.8.3 Middle East and Africa Conjunctivitis Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Conjunctivitis Sales by Type (2020-2031)

4.1.1 Global Conjunctivitis Sales by Type (2020-2025)

4.1.2 Global Conjunctivitis Sales by Type (2026-2031)

4.1.3 Global Conjunctivitis Sales Market Share by Type (2020-2031)

4.2 Global Conjunctivitis Revenue by Type (2020-2031)

4.2.1 Global Conjunctivitis Revenue by Type (2020-2025)

4.2.2 Global Conjunctivitis Revenue by Type (2026-2031)

4.2.3 Global Conjunctivitis Revenue Market Share by Type (2020-2031)

4.3 Global Conjunctivitis Price by Type (2020-2031)

5 Segment by End User

5.1 Global Conjunctivitis Sales by End User (2020-2031)

5.1.1 Global Conjunctivitis Sales by End User (2020-2025)

5.1.2 Global Conjunctivitis Sales by End User (2026-2031)

5.1.3 Global Conjunctivitis Sales Market Share by End User (2020-2031)

5.2 Global Conjunctivitis Revenue by End User (2020-2031)

5.2.1 Global Conjunctivitis Revenue by End User (2020-2025)

5.2.2 Global Conjunctivitis Revenue by End User (2026-2031)

5.2.3 Global Conjunctivitis Revenue Market Share by End User (2020-2031)

5.3 Global Conjunctivitis Price by End User (2020-2031)

6 Key Companies Profiled

6.1 Novartis (CH)

6.1.1 Novartis (CH) Company Information

6.1.2 Novartis (CH) Description and Business Overview

6.1.3 Novartis (CH) Conjunctivitis Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Novartis (CH) Conjunctivitis Product Portfolio

6.1.5 Novartis (CH) Recent Developments/Updates

6.2 Santen Pharmaceutical (JP)

6.2.1 Santen Pharmaceutical (JP) Company Information

6.2.2 Santen Pharmaceutical (JP) Description and Business Overview

6.2.3 Santen Pharmaceutical (JP) Conjunctivitis Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Santen Pharmaceutical (JP) Conjunctivitis Product Portfolio

6.2.5 Santen Pharmaceutical (JP) Recent Developments/Updates

6.3 Bausch & Lomb (US)

6.3.1 Bausch & Lomb (US) Company Information

6.3.2 Bausch & Lomb (US) Description and Business Overview

6.3.3 Bausch & Lomb (US) Conjunctivitis Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Bausch & Lomb (US) Conjunctivitis Product Portfolio

6.3.5 Bausch & Lomb (US) Recent Developments/Updates

6.4 Allergan (US)

6.4.1 Allergan (US) Company Information

6.4.2 Allergan (US) Description and Business Overview

6.4.3 Allergan (US) Conjunctivitis Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Allergan (US) Conjunctivitis Product Portfolio

6.4.5 Allergan (US) Recent Developments/Updates

6.5 Sun Pharmaceutical (ID)

6.5.1 Sun Pharmaceutical (ID) Company Information

6.5.2 Sun Pharmaceutical (ID) Description and Business Overview

6.5.3 Sun Pharmaceutical (ID) Conjunctivitis Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Sun Pharmaceutical (ID) Conjunctivitis Product Portfolio

6.5.5 Sun Pharmaceutical (ID) Recent Developments/Updates

6.6 Akorn (US)

6.6.1 Akorn (US) Company Information

6.6.2 Akorn (US) Description and Business Overview

6.6.3 Akorn (US) Conjunctivitis Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Akorn (US) Conjunctivitis Product Portfolio

6.6.5 Akorn (US) Recent Developments/Updates

6.7 Freda (CN)

6.7.1 Freda (CN) Company Information

6.7.2 Freda (CN) Description and Business Overview

6.7.3 Freda (CN) Conjunctivitis Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Freda (CN) Conjunctivitis Product Portfolio

6.7.5 Freda (CN) Recent Developments/Updates

6.8 Sinqi (CN)

6.8.1 Sinqi (CN) Company Information

6.8.2 Sinqi (CN) Description and Business Overview

6.8.3 Sinqi (CN) Conjunctivitis Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Sinqi (CN) Conjunctivitis Product Portfolio

6.8.5 Sinqi (CN) Recent Developments/Updates

6.9 Univision (CN)

6.9.1 Univision (CN) Company Information

6.9.2 Univision (CN) Description and Business Overview

6.9.3 Univision (CN) Conjunctivitis Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Univision (CN) Conjunctivitis Product Portfolio

6.9.5 Univision (CN) Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Conjunctivitis Industry Chain Analysis

7.2 Conjunctivitis Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Conjunctivitis Production Mode & Process Analysis

7.4 Conjunctivitis Sales and Marketing

7.4.1 Conjunctivitis Sales Channels

7.4.2 Conjunctivitis Distributors

7.5 Conjunctivitis Customer Analysis

8 Conjunctivitis Market Dynamics

8.1 Conjunctivitis Industry Trends

8.2 Conjunctivitis Market Drivers

8.3 Conjunctivitis Market Challenges

8.4 Conjunctivitis Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Conjunctivitis Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Conjunctivitis Market Value by End User (2024 VS 2031) & (US$ Million)

Table 3. Global Conjunctivitis Market Competitive Situation by Manufacturers in 2024

Table 4. Global Conjunctivitis Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Conjunctivitis Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Conjunctivitis Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Conjunctivitis Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Conjunctivitis Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Conjunctivitis, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Conjunctivitis, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Conjunctivitis, Product Type & Application

Table 12. Global Key Manufacturers of Conjunctivitis, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Conjunctivitis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Conjunctivitis as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Conjunctivitis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Conjunctivitis Sales by Region (2020-2025) & (K Units)

Table 18. Global Conjunctivitis Sales Market Share by Region (2020-2025)

Table 19. Global Conjunctivitis Sales by Region (2026-2031) & (K Units)

Table 20. Global Conjunctivitis Sales Market Share by Region (2026-2031)

Table 21. Global Conjunctivitis Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Conjunctivitis Revenue Market Share by Region (2020-2025)

Table 23. Global Conjunctivitis Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Conjunctivitis Revenue Market Share by Region (2026-2031)

Table 25. North America Conjunctivitis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Conjunctivitis Sales by Country (2020-2025) & (K Units)

Table 27. North America Conjunctivitis Sales by Country (2026-2031) & (K Units)

Table 28. North America Conjunctivitis Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Conjunctivitis Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Conjunctivitis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Conjunctivitis Sales by Country (2020-2025) & (K Units)

Table 32. Europe Conjunctivitis Sales by Country (2026-2031) & (K Units)

Table 33. Europe Conjunctivitis Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Conjunctivitis Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Conjunctivitis Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Conjunctivitis Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Conjunctivitis Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Conjunctivitis Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Conjunctivitis Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Conjunctivitis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Conjunctivitis Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Conjunctivitis Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Conjunctivitis Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Conjunctivitis Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Conjunctivitis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Conjunctivitis Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Conjunctivitis Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Conjunctivitis Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Conjunctivitis Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Conjunctivitis Sales (K Units) by Type (2020-2025)

Table 51. Global Conjunctivitis Sales (K Units) by Type (2026-2031)

Table 52. Global Conjunctivitis Sales Market Share by Type (2020-2025)

Table 53. Global Conjunctivitis Sales Market Share by Type (2026-2031)

Table 54. Global Conjunctivitis Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Conjunctivitis Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Conjunctivitis Revenue Market Share by Type (2020-2025)

Table 57. Global Conjunctivitis Revenue Market Share by Type (2026-2031)

Table 58. Global Conjunctivitis Price (USD/Unit) by Type (2020-2025)

Table 59. Global Conjunctivitis Price (USD/Unit) by Type (2026-2031)

Table 60. Global Conjunctivitis Sales (K Units) by End User (2020-2025)

Table 61. Global Conjunctivitis Sales (K Units) by End User (2026-2031)

Table 62. Global Conjunctivitis Sales Market Share by End User (2020-2025)

Table 63. Global Conjunctivitis Sales Market Share by End User (2026-2031)

Table 64. Global Conjunctivitis Revenue (US$ Million) by End User (2020-2025)

Table 65. Global Conjunctivitis Revenue (US$ Million) by End User (2026-2031)

Table 66. Global Conjunctivitis Revenue Market Share by End User (2020-2025)

Table 67. Global Conjunctivitis Revenue Market Share by End User (2026-2031)

Table 68. Global Conjunctivitis Price (USD/Unit) by End User (2020-2025)

Table 69. Global Conjunctivitis Price (USD/Unit) by End User (2026-2031)

Table 70. Novartis (CH) Company Information

Table 71. Novartis (CH) Description and Business Overview

Table 72. Novartis (CH) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Novartis (CH) Conjunctivitis Product

Table 74. Novartis (CH) Recent Developments/Updates

Table 75. Santen Pharmaceutical (JP) Company Information

Table 76. Santen Pharmaceutical (JP) Description and Business Overview

Table 77. Santen Pharmaceutical (JP) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Santen Pharmaceutical (JP) Conjunctivitis Product

Table 79. Santen Pharmaceutical (JP) Recent Developments/Updates

Table 80. Bausch & Lomb (US) Company Information

Table 81. Bausch & Lomb (US) Description and Business Overview

Table 82. Bausch & Lomb (US) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Bausch & Lomb (US) Conjunctivitis Product

Table 84. Bausch & Lomb (US) Recent Developments/Updates

Table 85. Allergan (US) Company Information

Table 86. Allergan (US) Description and Business Overview

Table 87. Allergan (US) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Allergan (US) Conjunctivitis Product

Table 89. Allergan (US) Recent Developments/Updates

Table 90. Sun Pharmaceutical (ID) Company Information

Table 91. Sun Pharmaceutical (ID) Description and Business Overview

Table 92. Sun Pharmaceutical (ID) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Sun Pharmaceutical (ID) Conjunctivitis Product

Table 94. Sun Pharmaceutical (ID) Recent Developments/Updates

Table 95. Akorn (US) Company Information

Table 96. Akorn (US) Description and Business Overview

Table 97. Akorn (US) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Akorn (US) Conjunctivitis Product

Table 99. Akorn (US) Recent Developments/Updates

Table 100. Freda (CN) Company Information

Table 101. Freda (CN) Description and Business Overview

Table 102. Freda (CN) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Freda (CN) Conjunctivitis Product

Table 104. Freda (CN) Recent Developments/Updates

Table 105. Sinqi (CN) Company Information

Table 106. Sinqi (CN) Description and Business Overview

Table 107. Sinqi (CN) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Sinqi (CN) Conjunctivitis Product

Table 109. Sinqi (CN) Recent Developments/Updates

Table 110. Univision (CN) Company Information

Table 111. Univision (CN) Description and Business Overview

Table 112. Univision (CN) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Univision (CN) Conjunctivitis Product

Table 114. Univision (CN) Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Conjunctivitis Distributors List

Table 118. Conjunctivitis Customers List

Table 119. Conjunctivitis Market Trends

Table 120. Conjunctivitis Market Drivers

Table 121. Conjunctivitis Market Challenges

Table 122. Conjunctivitis Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Product Picture of Conjunctivitis

Figure 2. Global Conjunctivitis Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Conjunctivitis Market Share by Type: 2024 & 2031

Figure 4. Antibiotic Product Picture

Figure 5. Pills Product Picture

Figure 6. Ointment Product Picture

Figure 7. Global Conjunctivitis Market Value by End User (2020-2031) & (US$ Million)

Figure 8. Global Conjunctivitis Market Share by End User: 2024 & 2031

Figure 9. Newborns

Figure 10. Children

Figure 11. Adults

Figure 12. Global Conjunctivitis Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Conjunctivitis Market Size (2020-2031) & (US$ Million)

Figure 14. Global Conjunctivitis Sales (2020-2031) & (K Units)

Figure 15. Global Conjunctivitis Average Price (USD/Unit) & (2020-2031)

Figure 16. Conjunctivitis Report Years Considered

Figure 17. Conjunctivitis Sales Share by Manufacturers in 2024

Figure 18. Global Conjunctivitis Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Conjunctivitis Players: Market Share by Revenue in Conjunctivitis in 2024

Figure 20. Conjunctivitis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Conjunctivitis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Conjunctivitis Sales Market Share by Country (2020-2031)

Figure 23. North America Conjunctivitis Revenue Market Share by Country (2020-2031)

Figure 24. U.S. Conjunctivitis Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Conjunctivitis Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Conjunctivitis Sales Market Share by Country (2020-2031)

Figure 27. Europe Conjunctivitis Revenue Market Share by Country (2020-2031)

Figure 28. Germany Conjunctivitis Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Conjunctivitis Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Conjunctivitis Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Conjunctivitis Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Conjunctivitis Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Conjunctivitis Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Conjunctivitis Revenue Market Share by Region (2020-2031)

Figure 35. China Conjunctivitis Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Conjunctivitis Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Conjunctivitis Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Conjunctivitis Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Conjunctivitis Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Conjunctivitis Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Indonesia Conjunctivitis Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Thailand Conjunctivitis Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Malaysia Conjunctivitis Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Philippines Conjunctivitis Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Latin America Conjunctivitis Sales Market Share by Country (2020-2031)

Figure 46. Latin America Conjunctivitis Revenue Market Share by Country (2020-2031)

Figure 47. Mexico Conjunctivitis Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Brazil Conjunctivitis Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Argentina Conjunctivitis Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Middle East and Africa Conjunctivitis Sales Market Share by Country (2020-2031)

Figure 51. Middle East and Africa Conjunctivitis Revenue Market Share by Country (2020-2031)

Figure 52. Turkey Conjunctivitis Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Conjunctivitis Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. U.A.E Conjunctivitis Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Global Sales Market Share of Conjunctivitis by Type (2020-2031)

Figure 56. Global Revenue Market Share of Conjunctivitis by Type (2020-2031)

Figure 57. Global Conjunctivitis Price (USD/Unit) by Type (2020-2031)

Figure 58. Global Sales Market Share of Conjunctivitis by End User (2020-2031)

Figure 59. Global Revenue Market Share of Conjunctivitis by End User (2020-2031)

Figure 60. Global Conjunctivitis Price (USD/Unit) by End User (2020-2031)

Figure 61. Conjunctivitis Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Conjunctivitis in 2031? zhanKai

The global market size of Conjunctivitis in 2031 was 4099 Million USD.

Which companies rank high in the global Conjunctivitis market? shouQi

Which region is expected to have the highest market share? shouQi

What was the global market size of Conjunctivitis in 2025? shouQi

What is the annual compound growth rate of the global Conjunctivitis market size from 2025 to 2031? shouQi

Related Reports

Global Conjunctivitis Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Conjunctivitis market size was US$ 3727 million in 2025 and is forecast to reach a readjusted size of US$ 4158 million by 2032 with a CAGR of 1.6% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 79
USD 4250.00
(Single User License)
Global Conjunctivitis Market Research Report 2026
The global Conjunctivitis market was valued at US$ 3727 million in 2025 and is anticipated to reach US$ 4158 million by 2032, at a CAGR of 1.6% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 109
USD 2900.00
(Single User License)
Conjunctivitis- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Conjunctivitis was estimated to be worth US$ 3727 million in 2025 and is projected to reach US$ 4158 million, growing at a CAGR of 1.6% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 109
USD 3950.00
(Single User License)
Global Conjunctivitis Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Conjunctivitis market is projected to grow from US$ 3674 million in 2024 to US$ 4099 million by 2031, at a CAGR of 1.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 133
USD 4900.00
(Single User License)
Global Conjunctivitis Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Conjunctivitis was estimated to be worth US$ 3674 million and is forecast to reach approximately US$ 4099 million by 2031 with a CAGR of 1.6% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 132
USD 5900.00
(Single User License)
Global Conjunctivitis Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Conjunctivitis market size was US$ 3674 million in 2024 and is forecast to a readjusted size of US$ 4099 million by 2031 with a CAGR of 1.6% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 76
USD 4250.00
(Single User License)
Conjunctivitis- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Conjunctivitis was estimated to be worth US$ 3674 million in 2024 and is forecast to a readjusted size of US$ 4099 million by 2031 with a CAGR of 1.6% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 102
USD 3950.00
(Single User License)
Global Conjunctivitis Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Conjunctivitis, or inflammation of the conjunctiva, is a general term that refers to a diverse group of diseases/disorders that affect the conjunctiva primarily. Most varieties of conjunctivitis are self-limited, but some progress and may cause serious ocular and extraocular complications.
Published Date: 2024-04-17
Pages: 141
USD 5600.00
(Single User License)
Global Conjunctivitis Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Conjunctivitis, or inflammation of the conjunctiva, is a general term that refers to a diverse group of diseases/disorders that affect the conjunctiva primarily. Most varieties of conjunctivitis are self-limited, but some progress and may cause serious ocular and extraocular complications.
Published Date: 2024-04-16
Pages: 125
USD 5900.00
(Single User License)
Global Conjunctivitis Market Insights, Forecast to 2030
Conjunctivitis, or inflammation of the conjunctiva, is a general term that refers to a diverse group of diseases/disorders that affect the conjunctiva primarily. Most varieties of conjunctivitis are self-limited, but some progress and may cause serious ocular and extraocular complications.
Published Date: 2024-04-07
Pages: 95
USD 4900.00
(Single User License)

Global Conjunctivitis Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Conjunctivitis market size was US$ 3727 million in 2025 and is forecast to reach a readjusted size of US$ 4158 million by 2032 with a CAGR of 1.6% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 79
USD 4250.00 (Single User License)
Global Conjunctivitis Market Research Report 2026
The global Conjunctivitis market was valued at US$ 3727 million in 2025 and is anticipated to reach US$ 4158 million by 2032, at a CAGR of 1.6% from 2026 to 2032.
Published: 2026-01-04
Pages: 109
USD 2900.00 (Single User License)
Conjunctivitis- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Conjunctivitis was estimated to be worth US$ 3727 million in 2025 and is projected to reach US$ 4158 million, growing at a CAGR of 1.6% from 2026 to 2032.
Published: 2026-01-04
Pages: 109
USD 3950.00 (Single User License)
Global Conjunctivitis Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Conjunctivitis market is projected to grow from US$ 3674 million in 2024 to US$ 4099 million by 2031, at a CAGR of 1.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 133
USD 4900.00 (Single User License)
Global Conjunctivitis Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Conjunctivitis was estimated to be worth US$ 3674 million and is forecast to reach approximately US$ 4099 million by 2031 with a CAGR of 1.6% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 132
USD 5900.00 (Single User License)
Global Conjunctivitis Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Conjunctivitis market size was US$ 3674 million in 2024 and is forecast to a readjusted size of US$ 4099 million by 2031 with a CAGR of 1.6% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 76
USD 4250.00 (Single User License)
Conjunctivitis- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Conjunctivitis was estimated to be worth US$ 3674 million in 2024 and is forecast to a readjusted size of US$ 4099 million by 2031 with a CAGR of 1.6% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 102
USD 3950.00 (Single User License)
Global Conjunctivitis Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Conjunctivitis, or inflammation of the conjunctiva, is a general term that refers to a diverse group of diseases/disorders that affect the conjunctiva primarily. Most varieties of conjunctivitis are self-limited, but some progress and may cause serious ocular and extraocular complications.
Published: 2024-04-17
Pages: 141
USD 5600.00 (Single User License)
Global Conjunctivitis Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Conjunctivitis, or inflammation of the conjunctiva, is a general term that refers to a diverse group of diseases/disorders that affect the conjunctiva primarily. Most varieties of conjunctivitis are self-limited, but some progress and may cause serious ocular and extraocular complications.
Published: 2024-04-16
Pages: 125
USD 5900.00 (Single User License)
Global Conjunctivitis Market Insights, Forecast to 2030
Conjunctivitis, or inflammation of the conjunctiva, is a general term that refers to a diverse group of diseases/disorders that affect the conjunctiva primarily. Most varieties of conjunctivitis are self-limited, but some progress and may cause serious ocular and extraocular complications.
Published: 2024-04-07
Pages: 95
USD 4900.00 (Single User License)